The retinoblastoma tumor suppressor inhibits cellular proliferation through two distinct mechanisms: Inhibition of cell cycle progression and induction of cell death

Karen E. Knudsen, Erich Weber, Karen C. Arden, Webster K. Cavenee, James R. Feramisco, Erik S. Knudsen

Research output: Contribution to journalArticle

53 Citations (Scopus)

Abstract

Studies aimed at examining the precise function(s) of the retinoblastoma tumor suppressor protein, RB, have been hindered by the rapid phosphorylation and inactivation of ectopically expressed RB which occurs in the majority of cell types. Therefore, ectopically expressed RB is a poor inhibitor of cellular proliferation. We have designed constitutively active RB proteins, PSM-RB, that cannot be inactivated by phosphorylation. Using these proteins, we show that unlike wild-type RB, PSM-RB proteins inhibit cell cycle progression in a broad range of tumor cell types. Furthermore, unlike p16(ink4a), PSM-RB is also a potent inhibitor of cell cycle progression in RB-deficient tumor cells. Surprisingly, we identified a tumor cell line that is resistant to the cell cycle inhibitory effects of PSM-RB. This finding challenges the hypothesis that RB must be inactivated in all cells for cell cycle progression to occur. Further characterization of this 'resistant' tumor line revealed that proliferation of these cells is still inhibited by PSM-RB. We show that this is due to PSM-RB-induced cell death. As such, these studies are the first to show that RB inhibits cellular proliferation through at least two distinct mechanisms- inhibition of cell cycle progression and induction of cell death.

Original languageEnglish (US)
Pages (from-to)5239-5245
Number of pages7
JournalOncogene
Volume18
Issue number37
DOIs
StatePublished - Sep 16 1999

Fingerprint

Retinoblastoma
Cell Cycle
Cell Death
Cell Proliferation
Neoplasms
Phosphorylation
Tumor Suppressor Proteins
Retinoblastoma Protein
Cell Cycle Proteins
Tumor Cell Line
Proteins

Keywords

  • Apoptosis
  • Cell death
  • Cyclin
  • Phosphorylation
  • RB

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

The retinoblastoma tumor suppressor inhibits cellular proliferation through two distinct mechanisms : Inhibition of cell cycle progression and induction of cell death. / Knudsen, Karen E.; Weber, Erich; Arden, Karen C.; Cavenee, Webster K.; Feramisco, James R.; Knudsen, Erik S.

In: Oncogene, Vol. 18, No. 37, 16.09.1999, p. 5239-5245.

Research output: Contribution to journalArticle

Knudsen, Karen E. ; Weber, Erich ; Arden, Karen C. ; Cavenee, Webster K. ; Feramisco, James R. ; Knudsen, Erik S. / The retinoblastoma tumor suppressor inhibits cellular proliferation through two distinct mechanisms : Inhibition of cell cycle progression and induction of cell death. In: Oncogene. 1999 ; Vol. 18, No. 37. pp. 5239-5245.
@article{38567b8bd2db44708fdd785eae7b8b8d,
title = "The retinoblastoma tumor suppressor inhibits cellular proliferation through two distinct mechanisms: Inhibition of cell cycle progression and induction of cell death",
abstract = "Studies aimed at examining the precise function(s) of the retinoblastoma tumor suppressor protein, RB, have been hindered by the rapid phosphorylation and inactivation of ectopically expressed RB which occurs in the majority of cell types. Therefore, ectopically expressed RB is a poor inhibitor of cellular proliferation. We have designed constitutively active RB proteins, PSM-RB, that cannot be inactivated by phosphorylation. Using these proteins, we show that unlike wild-type RB, PSM-RB proteins inhibit cell cycle progression in a broad range of tumor cell types. Furthermore, unlike p16(ink4a), PSM-RB is also a potent inhibitor of cell cycle progression in RB-deficient tumor cells. Surprisingly, we identified a tumor cell line that is resistant to the cell cycle inhibitory effects of PSM-RB. This finding challenges the hypothesis that RB must be inactivated in all cells for cell cycle progression to occur. Further characterization of this 'resistant' tumor line revealed that proliferation of these cells is still inhibited by PSM-RB. We show that this is due to PSM-RB-induced cell death. As such, these studies are the first to show that RB inhibits cellular proliferation through at least two distinct mechanisms- inhibition of cell cycle progression and induction of cell death.",
keywords = "Apoptosis, Cell death, Cyclin, Phosphorylation, RB",
author = "Knudsen, {Karen E.} and Erich Weber and Arden, {Karen C.} and Cavenee, {Webster K.} and Feramisco, {James R.} and Knudsen, {Erik S.}",
year = "1999",
month = "9",
day = "16",
doi = "10.1038/sj.onc.1202910",
language = "English (US)",
volume = "18",
pages = "5239--5245",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "37",

}

TY - JOUR

T1 - The retinoblastoma tumor suppressor inhibits cellular proliferation through two distinct mechanisms

T2 - Inhibition of cell cycle progression and induction of cell death

AU - Knudsen, Karen E.

AU - Weber, Erich

AU - Arden, Karen C.

AU - Cavenee, Webster K.

AU - Feramisco, James R.

AU - Knudsen, Erik S.

PY - 1999/9/16

Y1 - 1999/9/16

N2 - Studies aimed at examining the precise function(s) of the retinoblastoma tumor suppressor protein, RB, have been hindered by the rapid phosphorylation and inactivation of ectopically expressed RB which occurs in the majority of cell types. Therefore, ectopically expressed RB is a poor inhibitor of cellular proliferation. We have designed constitutively active RB proteins, PSM-RB, that cannot be inactivated by phosphorylation. Using these proteins, we show that unlike wild-type RB, PSM-RB proteins inhibit cell cycle progression in a broad range of tumor cell types. Furthermore, unlike p16(ink4a), PSM-RB is also a potent inhibitor of cell cycle progression in RB-deficient tumor cells. Surprisingly, we identified a tumor cell line that is resistant to the cell cycle inhibitory effects of PSM-RB. This finding challenges the hypothesis that RB must be inactivated in all cells for cell cycle progression to occur. Further characterization of this 'resistant' tumor line revealed that proliferation of these cells is still inhibited by PSM-RB. We show that this is due to PSM-RB-induced cell death. As such, these studies are the first to show that RB inhibits cellular proliferation through at least two distinct mechanisms- inhibition of cell cycle progression and induction of cell death.

AB - Studies aimed at examining the precise function(s) of the retinoblastoma tumor suppressor protein, RB, have been hindered by the rapid phosphorylation and inactivation of ectopically expressed RB which occurs in the majority of cell types. Therefore, ectopically expressed RB is a poor inhibitor of cellular proliferation. We have designed constitutively active RB proteins, PSM-RB, that cannot be inactivated by phosphorylation. Using these proteins, we show that unlike wild-type RB, PSM-RB proteins inhibit cell cycle progression in a broad range of tumor cell types. Furthermore, unlike p16(ink4a), PSM-RB is also a potent inhibitor of cell cycle progression in RB-deficient tumor cells. Surprisingly, we identified a tumor cell line that is resistant to the cell cycle inhibitory effects of PSM-RB. This finding challenges the hypothesis that RB must be inactivated in all cells for cell cycle progression to occur. Further characterization of this 'resistant' tumor line revealed that proliferation of these cells is still inhibited by PSM-RB. We show that this is due to PSM-RB-induced cell death. As such, these studies are the first to show that RB inhibits cellular proliferation through at least two distinct mechanisms- inhibition of cell cycle progression and induction of cell death.

KW - Apoptosis

KW - Cell death

KW - Cyclin

KW - Phosphorylation

KW - RB

UR - http://www.scopus.com/inward/record.url?scp=0033575960&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033575960&partnerID=8YFLogxK

U2 - 10.1038/sj.onc.1202910

DO - 10.1038/sj.onc.1202910

M3 - Article

C2 - 10498874

AN - SCOPUS:0033575960

VL - 18

SP - 5239

EP - 5245

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 37

ER -